Oruka Therapeutics, Inc. (ORKA)

NGM – Real vaqt narxi. Valyuta: USD

90.60

+3.97 (4.58%)

Yopilishda: Jun 26, 2026, 4:00 PM EDT

90.58

-0.02 (-0.02%)

Bozordan keyin: Jun 26, 2026, 7:34 PM EDT

Kompaniya haqida

Oruka Therapeutics, Inc., klinik bosqichdagi biofarmatsevtika kompaniyasi, psoriaz (PsO) va boshqa yallig'lanish va immunologik (I&I) ko'rsatmalari uchun yangi monoklonal antitelalardan iborat terapevtik vositalarni ishlab chiqishga qaratilgan. Uning asosiy mahsulotlari orasida psoriazni (PsO) davolash uchun 2a fazali sinovda bo'lgan va interleikin-23 ning p19 subbirligiga qaratilgan ORKA-001; va psoriazni (PsO), psoriatik artritni va boshqa sharoitlarni davolash uchun 2-fazali sinovda bo'lgan va interleikin-17A va interleikin-17F ga qaratilgan ORKA-002 mavjud. Kompaniya, shuningdek, ko'rsatilmagan yo'nalishga qaratilgan ORKA-003; va ORKA-002 va ORKA-001 ning ketma-ket kombinatsiyalangan rejimi bo'lgan ORKA-021 ni ishlab chiqadi. Oruka Therapeutics, Inc. Kaliforniyaning Menlo Park shahrida joylashgan.

Asosiy rahbarlar

Ism	Lavozim
Dr. Joana Goncalves M.D.	Chief Medical Officer
Dr. Lawrence Otto Klein Ph.D.	President, CEO & Director
Dr. Rajiv Panwar	Senior VP and Head of Chemistry, Manufacturing & Controls
Mr. Alan Lada	VP of IR & Capital Markets
Mr. Arjun Agarwal CPA	Senior VP of Finance & Treasurer
Mr. Christopher Finch	Senior VP and Head of Business Development & Strategy